Theravance Biopharma Inc. (TBPH) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-10-08
08:36 am
Sale
2021-09-3013GTHERAVANCE BIOPHARMA INC
TBPH
WELLINGTON MANAGEMENT GROUP LLP250,219
0.340%
-7,352,526decrease
(-96.71%)
Filing
History
2021-09-27
4:46 pm
Purchase
2021-09-1513GTHERAVANCE BIOPHARMA INC
TBPH
Madison Avenue Partners LP4,567,413
6.200%
4,567,413increase
(New Position)
Filing
History
2021-09-07
4:35 pm
Purchase
2021-08-2513GTHERAVANCE BIOPHARMA INC
TBPH
Point72 Asset Management L.P.5,144,637
7.000%
5,144,637increase
(New Position)
Filing
History
2021-04-12
08:02 am
Purchase
2021-03-3113GTHERAVANCE BIOPHARMA INC
TBPH
WELLINGTON MANAGEMENT GROUP LLP7,602,745
11.660%
1,993,118increase
(+35.53%)
Filing
History
Goto Prev, 0, 1, 2